Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma : Japan Clinical Oncology Group study (JCOG 9305)

• OGURA Michinori

  Department of Hematology and Chemotherapy, Aichi Cancer Center Hospital

• ITOH Kuniaki

  Division of Hematology and Oncology, National Cancer Center Hospital East

• KINOSHITA Tomohiro

  Department of Hematology and Oncology, Nagoya University Graduate School of Medicine

• FUKUDA Haruhiko

  JCOG Data Center, Center for Cancer Control and Information Services, National Cancer Center

• TAKENAKA Takeaki

  Hematology Division, National Cancer Center Hospital

• OHTSU Tomoko

  Division of Hematology and Oncology, National Cancer Center Hospital East

• KAGAMI Yoshitoyo

  Department of Hematology and Chemotherapy, Aichi Cancer Center Hospital

• TOBINAI Kensei

  Hematology Division, National Cancer Center Hospital

• OKAMOTO Masataka

  Department of Medicine, Fujita Health University School of Medicine

• ASAOKU Hideki

  Department of Hematology, Hiroshima Red Cross Hospital

• SASAKI Tsuneo

  Department of Chemotherapy, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital

• MIKUNI Chikara

  Department of Hematology, Sapporo National Hospital

• HIRANO Masami

  Department of Medicine, Fujita Health University School of Medicine

• CHOU Takaaki

  Department of Internal Medicine, Niigata Cancer Center Hospital

• OHNISHI Kazunori

  The 3rd Department of Internal Medicine, Hamamatsu University School of Medicine

• OHNO Hitoshi

  Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University

• NASU Kaori

  Department of Hematology, Osaka Red Cross Hospital

• OKABE Kenichi

  Department of Hematology, Shikoku National Hospital

• IKEDA Shuichi

  Department of Hematology, Sasebo City General Hospital

• NAKAMURA Shigeo

  Department of Pathology, Aichi Cancer Center Hospital

• HOTTA Tomomitsu

  Department of Hematology and Oncology, Tokai University School of Medicine

• SHIMOYAMA Masanori

  Hematology Division, National Cancer Center Hospital

収録刊行物

• International journal of hematology

  International journal of hematology 92 (5), 713-724, 2010-12-15

キーワード

• Hodgkin lymphoma
• Chemotherapy
• ABVd therapy
• Phase II study

詳細情報

• CRID: 1573105976067302528
• NII論文ID: 10027674421
• NII書誌ID: AA10797094
• ISSN: 09255710
• Web Site: https://search.jamas.or.jp/link/ui/2011287496
• 本文言語コード: en
• データソース種別:
  • CiNii Articles